We're All One Crisis Away from Taking Unlicensed Research Peptidesasteriskmag.com 8 pointsmaxall43 months ago2 commentsSaveHideCopy link On HNComments−ArneBab3moSummary:1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»That’s a pretty bad outlook.−rini173moThis is incredibly bad summary. If it were about prescription meds, they can be bought on gray market, problem solved.
Comments
Summary:
1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.
2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»
That’s a pretty bad outlook.
This is incredibly bad summary. If it were about prescription meds, they can be bought on gray market, problem solved.